Generex Biotechnology Announces Shareholder Conference Call Scheduled for Thursday May 6, 2021
Miramar, FL April 12, 2021 NuGenerex Immuno-Oncology (NGIO – www.nugenerexio.com), a subsidiary of Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated…